PEAKS: Validation of Mobile Technologies

Completed

Conditions studied: Health Services for Persons With Disabilities, Disability Evaluation, Exercise, Fitness Trackers, Validation Studies

In brief

The overall objective of this project is to evaluate and validate the accuracy and usability of a deployed beta sensor-based system. This is a cross-sectional validation study of 100 apparently health community dwelling adults aged 60+ years. Participants will perform standardized lifestyle, exercise and sedentary type physical activities in a clinic laboratory and home setting.

Key facts

Study ID

NCT02888483

Run by

University of Florida

People needed

113

Starts

2016-07-01

Expected to finish

2018-05-11

Last updated by the study team

2019-05-13

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 60+ years old
• Community dwelling adults without significant health issues that would impact safety of participation
• Willingness to undergo all testing procedures
• Weight stable for at least three months
• Able to understand and speak English

You may not qualify if…

• Failure to provide informed consent
• Use of walker (use of a cane is permitted)
• Lower extremity amputation
• Develops chest pain or severe shortness of breath during physical stress
• Post-stroke syndrome causing ambulatory deficits (other stroke survivors permitted)
• Needs assistance with basic activities of daily living: feeding, dressing, continence, bathing, toileting, and transferring from a bed to a chair or from a chair to walking
• Lives in a nursing home; persons living in assisted or independent housing are not excluded
• Heavy drinking as drinking 5 or more drinks on the same occasion on each of 5 or more days in the past 30 days.
• For women who are child-bearing age (up to 62 years of age): pregnancy or breast-feeding
• Participation in a structured weight loss program or fad diet in the last month
• Weight reduction surgery in the past year
• Known neuromuscular disorder that restricts activity (e.g. Rhabdomyolysis, Myasthenia Gravis, Ataxia, Apraxia, post-polio syndrome, mitochondrial myopathy, etc.)
• Diagnosed neuropathy that causes pain that restricts activity
• Symptomatic peripheral arterial disease that restricts activity
• Unable to communicate because of severe hearing loss or speech disorder
• Severe visual impairment, which would preclude completion of the assessments
• Progressive, degenerative neurologic disease (e.g., Parkinson's Disease, Multiple Sclerosis, ALS)
• Severe rheumatologic or orthopedic diseases that significantly restricts activity (e.g., awaiting joint replacement, active inflammatory disease)
• Terminal illness, as determined by a physician
• Severe pulmonary disease, requiring the use of supplemental oxygen or steroid therapy
• Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, recent history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
• Other significant comorbid disease discovered during medical screening that would elicit safety concerns, (e.g. renal failure on hemodialysis, psychiatric disorder, chronic fatigue syndrome, etc.)
• Pacemakers and implanted cardiac defibrillators

Where it is running

• UF Institute on Aging Clinical and Translational Research Building — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.